{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:19:39Z","timestamp":1792995579131,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.thromres.2025.109352","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T06:24:58Z","timestamp":1748067898000},"page":"109352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"252","author":[{"given":"Nicholas L.J.","family":"Chornenki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roupen","family":"Odabashian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenneke","family":"Lenteejens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Stucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Tritschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109352_bb0005","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"Lopez-Lopez","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2025.109352_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/VHRM.S121661","article-title":"Evaluation of bleeding in patients receiving direct oral anticoagulants","volume":"13","author":"Hellenbart","year":"2017","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.thromres.2025.109352_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2019.05.019","article-title":"It\u2019s time for head-to-head trials with direct oral anticoagulants","volume":"180","author":"Tritschler","year":"2019","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2025.109352_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004517","article-title":"Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish patients","volume":"6","author":"Lamberts","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.thromres.2025.109352_bb0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109352_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STROKEAHA.107.495036","article-title":"Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians","volume":"39","author":"Gattellari","year":"2008","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.thromres.2025.109352_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1155\/2012\/862905","article-title":"Why do mortality rates for nonvariceal upper gastrointestinal bleeding differ around the world? A systematic review of cohort studies","volume":"26","author":"V Jairath","year":"2012","journal-title":"Can. J. Gastroenterol."},{"issue":"20","key":"10.1016\/j.thromres.2025.109352_bb0040","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/eurheartj\/ehu463","article-title":"Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial","volume":"36","author":"Held","year":"2015","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.thromres.2025.109352_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.thromres.2025.109352_bb0050","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2025.109352_bb0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCULATIONAHA.118.036710","article-title":"Idarucizumab for dabigatran reversal in the management of patients with gastrointestinal bleeding","volume":"139","author":"Van der Wall","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.thromres.2025.109352_bb0060","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jth.13139","article-title":"Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Chai-Adisaksopha","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109352_bb0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"Hankey","year":"2014","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.thromres.2025.109352_bb0070","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism\u202f: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"23","key":"10.1016\/j.thromres.2025.109352_bb0075","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.jacc.2016.10.005","article-title":"Anticoagulant-related bleeding and mortality","volume":"68","author":"Connolly","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2025.109352_bb0080","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.thromres.2025.109352_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13643-022-02146-5","article-title":"All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis","volume":"11","author":"Chornenki","year":"2022","journal-title":"Syst. Rev."},{"issue":"8","key":"10.1016\/j.thromres.2025.109352_bb0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jclinepi.2014.03.003","article-title":"In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias","volume":"67","author":"Hunter","year":"2014","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109352_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.thromres.2025.109352_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ahj.2019.07.012","article-title":"Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: insights from a nationwide cohort","volume":"216","author":"Butt","year":"2019","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.thromres.2025.109352_bb0105","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-0038-1636541","article-title":"Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: a prospective cohort study","volume":"118","author":"Schulman","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109352_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2016.11.117","article-title":"Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life","volume":"227","author":"Becattini","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109352_bb0115","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.thromres.2015.10.036","article-title":"Emergency admissions for major haemorrhage associated with direct oral anticoagulants","volume":"136","author":"Bouget","year":"2015","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109352_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2017.11.007","article-title":"Severity of gastrointestinal bleeding in patients treated with direct-acting oral anticoagulants","volume":"131","author":"Brodie","year":"2018","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109352_bb0125","article-title":"Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleeding","volume":"3","author":"Cohen","year":"2022","journal-title":"J Am Coll Emerg Physicians Open."},{"key":"10.1016\/j.thromres.2025.109352_bb0130","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819851677","article-title":"Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study","volume":"12","author":"Deutsch","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109352_bb0135","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/jamainternmed.2016.5954","article-title":"Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation","volume":"176","author":"Graham","year":"2016","journal-title":"JAMA Intern. Med."},{"issue":"18","key":"10.1016\/j.thromres.2025.109352_bb0140","first-page":"312","article-title":"Severe hemorrhage associated with oral anticoagulants","volume":"117","author":"Lindhoff-Last","year":"2020","journal-title":"Dtsch. Arztebl. Int."},{"issue":"15","key":"10.1016\/j.thromres.2025.109352_bb0145","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1182\/blood-2017-05-782060","article-title":"Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study","volume":"130","author":"Majeed","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2025.109352_bb0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajem.2017.08.042","article-title":"Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: a retrospective multi-center analysis","volume":"36","author":"Milling","year":"2018","journal-title":"Am. J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109352_bb0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11739-019-02229-7","article-title":"Thirty-day mortality in atrial fibrillation patients with gastrointestinal bleeding in the emergency department: differences between direct oral anticoagulant and warfarin users","volume":"15","author":"Turcato","year":"2020","journal-title":"Intern. Emerg. Med."},{"issue":"10","key":"10.1016\/j.thromres.2025.109352_bb0160","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/imj.14459","article-title":"Idarucizumab for dabigatran reversal: the first 6 months in a tertiary Centre","volume":"49","author":"Wheeler","year":"2019","journal-title":"Intern. Med. J."},{"issue":"2","key":"10.1016\/j.thromres.2025.109352_bb0165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1076029616684030","article-title":"Characteristics, management, and outcomes of patients with atrial fibrillation experiencing a major bleeding event while on rivaroxaban","volume":"24","author":"Burgos","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109352_bb0170","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/ajg.2017.39","article-title":"A comparison of the rate of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants or warfarin","volume":"112","author":"Cangemi","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2025.109352_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajem.2023.07.042","article-title":"Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding","volume":"73","author":"Brown","year":"2023","journal-title":"Am. J. Emerg. Med."},{"issue":"16","key":"10.1016\/j.thromres.2025.109352_bb0180","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/CIRCULATIONAHA.123.066933","article-title":"The efficacy and safety of andexanet alfa in patients with acute gastrointestinal bleeding while taking factor Xa inhibitors: an ANNEXA-4 subanalysis","volume":"149","author":"Siegal","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2025.109352_bb0185","first-page":"72","article-title":"Use of andexanet in severe upper GI bleeding in a teaching hospital over a 16-month period","author":"Lloyd C","year":"2023","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.thromres.2025.109352_bb0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11239-021-02536-x","article-title":"Efficacy of prothrombin complex concentrate in the management of oral factor Xa inhibitors associated major bleed assessed by ISTH and ANNEXA-4 criteria","volume":"53","author":"Dev","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"issue":"24","key":"10.1016\/j.thromres.2025.109352_bb0195","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.thromres.2025.109352_bb0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ajg.2009.507","article-title":"Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases","volume":"105","author":"Sung","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2025.109352_bb0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2019.06.003","article-title":"Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding","volume":"180","author":"Little","year":"2019","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109352_bb0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/jth.15111","article-title":"Management of antithrombotic therapy after gastrointestinal bleeding: a mixed methods study of health-care providers","volume":"19","author":"Little","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2025.109352_bb0215","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jth.15476","article-title":"Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Candeloro","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"13","key":"10.1016\/j.thromres.2025.109352_bb0220","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final study report of andexanet alfa for major bleeding with factor Xa inhibitors","volume":"147","author":"Milling","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.thromres.2025.109352_bb0225","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.thromres.2025.109352_bb0230","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jacc.2013.05.042","article-title":"Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation","volume":"62","author":"Eikelboom","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2025.109352_bb0235","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:16:04Z","timestamp":1751415364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0049384825001021"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109352","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109352"}}